Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.

Pozzessere C, Bouchaab H, Jumeau R, Letovanec I, Daccord C, Bourhis J, Prior JO, Peters S, Lazor R, Beigelman-Aubry C.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00165-2019. doi: 10.1183/23120541.00165-2019. eCollection 2020 Jan.

2.

Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1).

Cicone F, Denoël T, Gnesin S, Riggi N, Irving M, Jakka G, Schaefer N, Viertl D, Coukos G, Prior JO.

Mol Imaging Biol. 2020 Mar 20. doi: 10.1007/s11307-020-01493-w. [Epub ahead of print]

PMID:
32198704
3.

Improving Nuclear Medicine Practice with UEMS/EBNM Committees.

Mirzaei S, Hustinx R, Prior JO, Ozcan Z, Boubaker A, Farsad M; European Union of Medical Specialists and European Board for Nuclear Medicine.

J Nucl Med. 2020 Mar;61(3):18N-20N. No abstract available.

PMID:
32123135
4.

Preclinical Evaluation and Dosimetry of [111In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1).

Cicone F, Denoël T, Gnesin S, Riggi N, Irving M, Jakka G, Schaefer N, Viertl D, Coukos G, Prior JO.

Mol Imaging Biol. 2020 Jan 28. doi: 10.1007/s11307-020-01479-8. [Epub ahead of print] Erratum in: Mol Imaging Biol. 2020 Mar 20;:.

PMID:
31993928
5.

18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer.

Mantziari S, Pomoni A, Prior JO, Winiker M, Allemann P, Demartines N, Schäfer M.

BMC Med Imaging. 2020 Jan 22;20(1):7. doi: 10.1186/s12880-019-0401-x.

6.

[Cardiology].

Meier D, Fournier S, Barras N, Regamey J, Rosset S, Pavon AG, Kamani CH, Deliniere A, Domenichini G, Graf D, Hullin R, Pascale P, Girod G, Eeckhout É, Schwitter J, Prior JO, Pruvot É, Bouchardy J, Monney P, Muller O, Rutz T.

Rev Med Suisse. 2020 Jan 15;16(676-7):16-22. French.

PMID:
31961076
7.

Increased 18F-FDG signal recovery from small physiological structures in digital PET/CT and application to the pituitary gland.

Meyer M, Allenbach G, Nicod Lalonde M, Schaefer N, Prior JO, Gnesin S.

Sci Rep. 2020 Jan 15;10(1):368. doi: 10.1038/s41598-019-57313-x.

8.

Phantom-based image quality assessment of clinical 18F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT.

Gnesin S, Kieffer C, Zeimpekis K, Papazyan JP, Guignard R, Prior JO, Verdun FR, Lima TVM.

EJNMMI Phys. 2020 Jan 6;7(1):1. doi: 10.1186/s40658-019-0269-4.

9.

Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.

Tabotta F, Jreige M, Schaefer N, Becce F, Prior JO, Nicod Lalonde M.

BMC Musculoskelet Disord. 2019 Dec 26;20(1):619. doi: 10.1186/s12891-019-3001-6.

10.

Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.

Meyer M, Nicod Lalonde M, Testart N, Jreige M, Kamani C, Boughdad S, Muoio B, Becce F, Schaefer N, Candrian C, Giovanella L, Prior JO, Treglia G, Riegger M.

Diagnostics (Basel). 2019 Dec 18;10(1). pii: E2. doi: 10.3390/diagnostics10010002. Review.

11.

A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems.

Denoël T, Pedrelli L, Pantaleo G, Prior JO.

Pharmaceuticals (Basel). 2019 Dec 3;12(4). pii: E177. doi: 10.3390/ph12040177.

12.

Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?

Pozzessere C, Bassanelli M, Ceribelli A, Rasul S, Li S, Prior JO, Cicone F.

Curr Urol Rep. 2019 Oct 11;20(11):68. doi: 10.1007/s11934-019-0938-9. Review.

PMID:
31605269
13.

Assessment of myocardial viability using a [15O]-water perfusion PET: Towards a one-stop shop?

Kamani CH, Prior JO.

J Nucl Cardiol. 2019 Aug 21. doi: 10.1007/s12350-019-01838-1. [Epub ahead of print] No abstract available.

PMID:
31435882
14.

Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and 18F-FDG PET/CT in Correlation with Clinical Pathologic Outcome.

Jreige M, Dunet V, Letovanec I, Prior JO, Meuli RA, Beigelman-Aubry C, Schaefer N.

J Nucl Med. 2020 Jan;61(1):26-32. doi: 10.2967/jnumed.119.229575. Epub 2019 Jun 21.

PMID:
31227574
15.

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Jreige M, Letovanec I, Chaba K, Renaud S, Rusakiewicz S, Cristina V, Peters S, Krueger T, de Leval L, Kandalaft LE, Nicod-Lalonde M, Romero P, Prior JO, Coukos G, Schaefer N.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1859-1868. doi: 10.1007/s00259-019-04348-x. Epub 2019 Jun 18.

PMID:
31214790
16.

Diagnostic Performance of PET or PET/CT Using 18F-FDG Labeled White Blood Cells in Infectious Diseases: A Systematic Review and a Bivariate Meta-Analysis.

Meyer M, Testart N, Jreige M, Kamani C, Moshebah M, Muoio B, Nicod-Lalonde M, Schaefer N, Giovanella L, Prior JO, Treglia G.

Diagnostics (Basel). 2019 Jun 15;9(2). pii: E60. doi: 10.3390/diagnostics9020060. Review.

17.

Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice.

Cicone F, Gnesin S, Denoël T, Stora T, van der Meulen NP, Müller C, Vermeulen C, Benešová M, Köster U, Johnston K, Amato E, Auditore L, Coukos G, Stabin M, Schaefer N, Viertl D, Prior JO.

EJNMMI Res. 2019 Jun 11;9(1):53. doi: 10.1186/s13550-019-0524-7.

18.

Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis.

Treglia G, Pereira Mestre R, Ferrari M, Bosetti DG, Pascale M, Oikonomou E, De Dosso S, Jermini F, Prior JO, Roggero E, Giovanella L.

Am J Nucl Med Mol Imaging. 2019 Apr 15;9(2):127-139. eCollection 2019.

19.

Low-Dose Imaging in a New Preclinical Total-Body PET/CT Scanner.

Molinos C, Sasser T, Salmon P, Gsell W, Viertl D, Massey JC, Mińczuk K, Li J, Kundu BK, Berr S, Correcher C, Bahadur A, Attarwala AA, Stark S, Junge S, Himmelreich U, Prior JO, Laperre K, Van Wyk S, Heidenreich M.

Front Med (Lausanne). 2019 May 3;6:88. doi: 10.3389/fmed.2019.00088. eCollection 2019.

20.

Detection Rate of 18F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis.

Treglia G, Annunziata S, Pizzuto DA, Giovanella L, Prior JO, Ceriani L.

Cancers (Basel). 2019 May 23;11(5). pii: E710. doi: 10.3390/cancers11050710. Review.

21.

First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE.

Savovic T, Prior JO, Nicod-Lalonde M, Bressoud A, Roux S, Schaefer N, Meyer M.

Med Oncol. 2019 Mar 27;36(5):41. doi: 10.1007/s12032-019-1266-0.

PMID:
30919094
22.

An International Survey of PET/CT Clinical Reporting.

Zukotynski KA, Niederkohr RD, Greenspan BS, Prior JO, Schöder H, Seltzer MA, Rohren EM, Yoo DC.

J Nucl Med. 2019 Apr;60(4):478-479. doi: 10.2967/jnumed.118.223073. Epub 2019 Mar 15. No abstract available.

23.

MR Volumetry of Lung Nodules: A Pilot Study.

Delacoste J, Dunet V, Dournes G, Lovis A, Rohner C, Elandoy C, Simons J, Long O, Piccini D, Stuber M, Prior JO, Nicod L, Beigelman-Aubry C.

Front Med (Lausanne). 2019 Feb 12;6:18. doi: 10.3389/fmed.2019.00018. eCollection 2019.

24.

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9.

Gnesin S, Cicone F, Mitsakis P, Van der Gucht A, Baechler S, Miralbell R, Garibotto V, Zilli T, Prior JO.

EJNMMI Res. 2018 Dec 12;8(1):108. doi: 10.1186/s13550-018-0462-9.

25.

PET-based prognostic survival model after radiotherapy for head and neck cancer.

Castelli J, Depeursinge A, Devillers A, Campillo-Gimenez B, Dicente Y, Prior JO, Chajon E, Jegoux F, Sire C, Acosta O, Gherga E, Sun X, De Bari B, Bourhis J, de Crevoisier R.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):638-649. doi: 10.1007/s00259-018-4134-9. Epub 2018 Aug 21.

PMID:
30132054
26.

Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis.

Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):751-765. doi: 10.1007/s00259-018-4123-z. Epub 2018 Aug 9.

PMID:
30094461
27.

Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.

Blanc-Durand P, Van Der Gucht A, Verger A, Langen KJ, Dunet V, Bloch J, Brouland JP, Nicod-Lalonde M, Schaefer N, Prior JO.

PLoS One. 2018 Jun 28;13(6):e0199379. doi: 10.1371/journal.pone.0199379. eCollection 2018.

28.

A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures.

Amato E, Cicone F, Auditore L, Baldari S, Prior JO, Gnesin S.

Phys Med. 2018 May;49:52-57. doi: 10.1016/j.ejmp.2018.05.005. Epub 2018 May 10.

PMID:
29866344
29.

Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.

Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, Ceriani L, Prior JO, Giovanella L, Slart RHJA.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1945-1955. doi: 10.1007/s00259-018-4013-4. Epub 2018 Apr 23.

PMID:
29687207
30.

Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.

Blanc-Durand P, Van Der Gucht A, Schaefer N, Itti E, Prior JO.

PLoS One. 2018 Apr 13;13(4):e0195798. doi: 10.1371/journal.pone.0195798. eCollection 2018.

31.

(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.

Cancer Radiother. 2018 May;22(3):229-235. doi: 10.1016/j.canrad.2017.10.003. Epub 2018 Apr 9.

PMID:
29650390
32.

Uptake of 99mTc-MIBI by Sclerosing Pneumocytoma Raising a False Suspicion of Metastasis From Medullary Thyroid Carcinoma.

Papadakis GE, Tabotta F, Levotanec I, Gonzalez M, Prior JO, La Rosa S, Sykiotis GP.

J Endocr Soc. 2018 Mar 23;2(4):386-390. doi: 10.1210/js.2018-00014. eCollection 2018 Apr 1.

33.

Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma.

Blanc-Durand P, Van Der Gucht A, Jreige M, Nicod-Lalonde M, Silva-Monteiro M, Prior JO, Denys A, Depeursinge A, Schaefer N.

Oncotarget. 2017 Dec 19;9(4):4549-4558. doi: 10.18632/oncotarget.23423. eCollection 2018 Jan 12.

34.

The Future of the Past Is the Present: The Role of the UEMS/EBNM in the Current Challenge of Educating Nuclear Medicine Specialists.

Frangos S, Hustinx R, Boubaker A, Varetto T, Prior JO, Siroos M, Maffioli L.

J Nucl Med. 2018 Mar;59(3):396-398. doi: 10.2967/jnumed.117.206052. Epub 2017 Dec 21. No abstract available.

35.

Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients.

Cottereau AS, El-Galaly TC, Becker S, Broussais F, Petersen LJ, Bonnet C, Prior JO, Tilly H, Hutchings M, Casasnovas O, Meignan M.

J Nucl Med. 2018 Apr;59(4):589-595. doi: 10.2967/jnumed.117.193946. Epub 2017 Sep 1.

36.

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC.

Baum RP, Singh A, Benešová M, Vermeulen C, Gnesin S, Köster U, Johnston K, Müller D, Senftleben S, Kulkarni HR, Türler A, Schibli R, Prior JO, van der Meulen NP, Müller C.

Dalton Trans. 2017 Oct 31;46(42):14638-14646. doi: 10.1039/c7dt01936j.

PMID:
28825750
37.

Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma.

Cicone F, Minniti G, Oliva MA, Carideo L, Prior JO, Scopinaro F, Giangaspero F, Arcella A.

Brain Tumor Pathol. 2017 Oct;34(4):179-181. doi: 10.1007/s10014-017-0296-6. Epub 2017 Aug 16. No abstract available.

PMID:
28815339
38.

Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study.

Morawiec B, Fournier S, Tapponnier M, Prior JO, Monney P, Dunet V, Lauriers N, Recordon F, Trana C, Iglesias JF, Kawecki D, Boulat O, Bardy D, Lamsidri S, Eeckhout E, Hugli O, Muller O.

BMJ Open. 2017 Jul 10;7(7):e014655. doi: 10.1136/bmjopen-2016-014655.

39.

First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK.

Gnesin S, Mitsakis P, Cicone F, Deshayes E, Dunet V, Gallino AF, Kosinski M, Baechler S, Buchegger F, Viertl D, Prior JO.

EJNMMI Res. 2017 Dec;7(1):43. doi: 10.1186/s13550-017-0288-x. Epub 2017 May 18.

40.

Cardiac Radionuclide Imaging in Rodents: A Review of Methods, Results, and Factors at Play.

Cicone F, Viertl D, Quintela Pousa AM, Denoël T, Gnesin S, Scopinaro F, Vozenin MC, Prior JO.

Front Med (Lausanne). 2017 Mar 29;4:35. doi: 10.3389/fmed.2017.00035. eCollection 2017.

41.

Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.

Prior JO, Gillessen S, Wirth M, Dale W, Aapro M, Oyen WJG.

Eur J Cancer. 2017 May;77:127-139. doi: 10.1016/j.ejca.2017.01.030. Epub 2017 Apr 7.

42.

Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?

Castelli J, Depeursinge A, de Bari B, Devillers A, de Crevoisier R, Bourhis J, Prior JO.

Clin Nucl Med. 2017 Jun;42(6):e281-e285. doi: 10.1097/RLU.0000000000001614.

PMID:
28288042
43.

A PET-based nomogram for oropharyngeal cancers.

Castelli J, Depeursinge A, Ndoh V, Prior JO, Ozsahin M, Devillers A, Bouchaab H, Chajon E, de Crevoisier R, Scher N, Jegoux F, Laguerre B, De Bari B, Bourhis J.

Eur J Cancer. 2017 Apr;75:222-230. doi: 10.1016/j.ejca.2017.01.018. Epub 2017 Feb 24.

PMID:
28237868
44.

18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma.

Jreige M, Mitsakis P, Van Der Gucht A, Pomoni A, Silva-Monteiro M, Gnesin S, Boubaker A, Nicod-Lalonde M, Duran R, Prior JO, Denys A, Schaefer N.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1215-1222. doi: 10.1007/s00259-017-3653-0. Epub 2017 Feb 23.

PMID:
28233086
45.

Cardiac PET/CT with Rb-82: optimization of image acquisition and reconstruction parameters.

Chilra P, Gnesin S, Allenbach G, Monteiro M, Prior JO, Vieira L, Pires Jorge JA.

EJNMMI Phys. 2017 Dec;4(1):10. doi: 10.1186/s40658-017-0178-3. Epub 2017 Feb 15.

46.

Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.

Dunet V, Halkic N, Prior JO, Anaye A, Meuli RA, Sempoux C, Denys A, Schmidt S.

Clin Nucl Med. 2017 Apr;42(4):258-263. doi: 10.1097/RLU.0000000000001538.

PMID:
28166142
47.

Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device.

Gnesin S, Leite Ferreira P, Malterre J, Laub P, Prior JO, Verdun FR.

Comput Math Methods Med. 2016;2016:4360371. doi: 10.1155/2016/4360371. Epub 2016 Dec 14.

48.

Resin Versus Glass Microspheres for 90Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry.

Van Der Gucht A, Jreige M, Denys A, Blanc-Durand P, Boubaker A, Pomoni A, Mitsakis P, Silva-Monteiro M, Gnesin S, Lalonde MN, Duran R, Prior JO, Schaefer N.

J Nucl Med. 2017 Aug;58(8):1334-1340. doi: 10.2967/jnumed.116.184713. Epub 2017 Jan 12.

49.

Comment on Hatzoglou et al: Dynamic contrast-enhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury.

Cicone F, Galldiks N, Minniti G, Filss CP, Scopinaro F, Prior JO, Albert NL, Langen KJ.

Neuro Oncol. 2017 Feb 1;19(2):300-301. doi: 10.1093/neuonc/now283. No abstract available. Erratum in: Neuro Oncol. 2017 Nov 29;19(12):1701.

50.

Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.

Gnesin S, Canetti L, Adib S, Cherbuin N, Silva Monteiro M, Bize P, Denys A, Prior JO, Baechler S, Boubaker A.

J Nucl Med. 2016 Nov;57(11):1672-1678. Epub 2016 Jun 15.

Supplemental Content

Loading ...
Support Center